Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

OMGA

Omega Therapeutics Inc

Dec 13 • 04:00PM ET

0.9690

Dollar change -0.0052
Percentage change -0.53	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN VRTX REGN GILD BIIB MRNA INCY BMRN ALNY SRPT

| Held by: VTI VXF IWC BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.33	Insider Own	65.08%	Shs Outstand	55.16M	Perf Week	0.63%
Market Cap	53.65M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.00%	Shs Float	19.33M	Perf Month	-9.44%
Income	-73.09M	PEG	-	EPS next Q	-0.23	Inst Own	23.80%	Short Float	29.34%	Perf Quarter	-27.14%
Sales	8.10M	P/S	6.62	EPS this Y	34.07%	Inst Trans	-12.50%	Short Ratio	18.51	Perf Half Y	-52.27%
Book/sh	0.21	P/B	4.63	EPS next Y	45.51%	ROA	-39.45%	Short Interest	5.67M	Perf Year	-63.98%
Cash/sh	0.55	P/C	1.75	EPS next 5Y	-	ROE	-166.90%	52W Range	0.75 - 6.30	Perf YTD	-67.81%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-48.08%	ROI	-59.06%	52W High	-84.62%	Beta	1.68
Dividend TTM	-	Quick Ratio	1.61	Sales past 5Y	347.21%	Gross Margin	9.71%	52W Low	29.20%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	1.61	EPS Y/Y TTM	36.45%	Oper. Margin	-916.00%	RSI (14)	50.31	Volatility	9.98% 12.01%
Employees	94	Debt/Eq	11.10	Sales Y/Y TTM	184.93%	Profit Margin	-902.93%	Recom	2.00	Target Price	4.00
Option/Short	Yes / Yes	LT Debt/Eq	9.72	EPS Q/Q	26.12%	Payout	-	Rel Volume	1.05	Prev Close	0.97
Sales Surprise	273.14%	EPS Surprise	-13.21%	Sales Q/Q	214.32%	Earnings	Nov 14 AMC	Avg Volume	306.44K	Price	0.97
SMA20	9.94%	SMA50	-5.55%	SMA200	-49.04%	Trades		Volume	321,770	Change	-0.53%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Downgrade	Raymond James	Outperform → Mkt Perform
Jun-18-24	Initiated	Raymond James	Outperform	$12
May-25-23	Resumed	Jefferies	Buy	$18 → $15
Dec-08-22	Initiated	H.C. Wainwright	Buy	$11
Sep-23-22	Initiated	Chardan Capital Markets	Buy	$12

Nov-20-24 08:00AM	Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies (PR Newswire)
06:30AM	Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer (PR Newswire)
Nov-14-24 05:40PM	Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -5.61% -17.98%
04:05PM	Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-13-24 08:00AM	Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio (PR Newswire) -6.14%
08:00AM	Loading…
08:00AM	Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner (PR Newswire)
Oct-23-24 08:00AM	Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence (PR Newswire)
Oct-15-24 08:00AM	Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings (GlobeNewswire) -6.05%
Oct-09-24 07:00AM	Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions (PR Newswire)
Oct-03-24 08:00AM	Invaio Sciences Appoints Andr Andonian as Chairman of the Board of Directors (PR Newswire)
Sep-26-24 06:00AM	Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry (PR Newswire)
Sep-17-24 07:00AM	Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications (GlobeNewswire)
Aug-14-24 07:00AM	Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research (GlobeNewswire)
Aug-06-24 01:53PM	OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +6.82%
08:10AM	Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Loading…
07:00AM	Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
06:30AM	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner (PR Newswire)
Jul-29-24 07:00AM	GSK and Flagship Pioneering partner to discover novel medicines and vaccines (PR Newswire)
Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-17-24 08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire) -5.26%
Jun-24-24 07:00AM	Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors (GlobeNewswire)
Jun-12-24 07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
May-30-24 07:00AM	Omega Therapeutics To Participate In Two Upcoming Investor Conferences (GlobeNewswire)
May-29-24 07:00AM	Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer (GlobeNewswire) -6.16%
May-09-24 07:00AM	Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management (PR Newswire)
May-08-24 07:00AM	Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers (GlobeNewswire)
May-06-24 02:52PM	OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -11.63%
08:10AM	Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Apr-25-24 10:02AM	Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:00AM	Loading…
Apr-23-24 07:00AM	Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting (GlobeNewswire)
Apr-17-24 09:55AM	Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) +6.02%
Apr-09-24 07:00AM	Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control (GlobeNewswire)
Apr-08-24 08:00AM	Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
Apr-03-24 12:00PM	Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-28-24 11:54PM	OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) -12.33%
10:25AM	Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
09:15AM	Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update (GlobeNewswire)
Mar-19-24 08:30AM	Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (PR Newswire)
Mar-06-24 07:00AM	Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire) +5.47%
Jan-09-24 11:01PM	The 3 Best Biotech Stocks to Buy in January 2024 (InvestorPlace) +19.71%
08:44AM	DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING (PR Newswire)
Jan-08-24 06:30AM	Flagship Pioneering Debuts Enabling Technologies Initiative (PR Newswire)
06:30AM	Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine (PR Newswire)
Jan-05-24 12:55PM	Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk (Zacks) -17.40%
Jan-04-24 06:08PM	Why Novo Nordisk Stock Crushed the Market Today (Motley Fool) +94.69%
04:01PM	Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity (Investor's Business Daily)
10:02AM	Novo Nordisk enters research partnerships with biotech firms (Yahoo Finance Video)
08:20AM	Why Is Omega Therapeutics (OMGA) Stock Up 111% Today? (InvestorPlace)
06:00AM	Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms (Reuters)
05:59AM	Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases (GlobeNewswire)
Jan-02-24 04:05PM	Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.08%
Dec-04-23 04:00PM	Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference (GlobeNewswire)
Nov-27-23 07:01PM	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders (PR Newswire)
Nov-21-23 06:00AM	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
Nov-20-23 04:00PM	Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire) -6.54%
Nov-13-23 07:00AM	Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis (GlobeNewswire)
Nov-09-23 07:00AM	Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire) -5.06%
Nov-07-23 04:00PM	Omega Therapeutics to Participate in The Jefferies London Healthcare Conference (GlobeNewswire)
Nov-01-23 10:30AM	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
Oct-31-23 07:00AM	Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller (GlobeNewswire) -7.43%
Oct-19-23 10:30AM	Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines (PR Newswire) -11.63%
Oct-16-23 07:00AM	Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC (GlobeNewswire)
Oct-11-23 04:00PM	Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD's The Liver Meeting 2023 (GlobeNewswire) -12.93% -6.77%
Oct-04-23 04:00PM	Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) +10.14%
Oct-02-23 07:00AM	Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics (PR Newswire) -12.09%
Sep-27-23 08:31AM	Flagship Pioneering Named to Fortune's 2023 'Change the World' List (PR Newswire)
Sep-26-23 07:00AM	Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO I Trial (GlobeNewswire) -23.17%
Sep-25-23 04:00PM	Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO I Trial on September 26 (GlobeNewswire)
Sep-21-23 04:00PM	Omega Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire) +5.37%
Sep-11-23 06:30AM	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer (PR Newswire)
Aug-29-23 07:00AM	Omega Therapeutics Announces Updates to its Board of Directors (GlobeNewswire) +8.29%
Aug-05-23 08:05AM	Omega Therapeutics Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Aug-03-23 05:15PM	Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Jul-20-23 07:39AM	Recursion (RXRX) Stock Surges 191% in 3 Months: Here's Why (Zacks) +8.85%
Jul-18-23 09:43AM	Corcept's (CORT) Early-Stage Study on NASH Reveals Positive Data (Zacks)
Jul-12-23 07:00AM	Omega Therapeutics Appoints Chris Schade to its Board of Directors (GlobeNewswire) +12.25%
Jul-03-23 11:20AM	Baudax Bio (BXRX) Up 125% on Acquiring TeraImmune (Zacks) -14.11%
Jun-22-23 09:18AM	Alderya (ALDX) Stock Declines on Getting CRL for PVRL Candidate (Zacks)
Jun-14-23 11:48AM	Recursion (RXRX) Up on Completing REC-994 Study Enrollment (Zacks)
Jun-08-23 11:49AM	Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001 (Zacks)
Jun-06-23 12:13PM	Bellerophon (BLPH) Down 87% as Lung Disease Candidate Fails (Zacks)
Jun-01-23 07:00AM	Omega Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire) -5.14%
May-31-23 08:30AM	Ashvattha Therapeutics Expands Leadership Team with Appointment of Paul E. Cayer as Chief Financial Officer and Mahesh Karande to the Board of Directors (GlobeNewswire)
07:00AM	Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting (GlobeNewswire)
May-25-23 09:55AM	Wall Street Analysts See a 59.64% Upside in Omega Therapeutics, Inc. (OMGA): Can the Stock Really Move This High? (Zacks) -9.24%
May-16-23 06:00AM	Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry (PR Newswire)
May-10-23 07:34AM	Investors in Omega Therapeutics (NASDAQ:OMGA) have seen impressive returns of 177% over the past year (Simply Wall St.) -5.46%
May-09-23 09:55AM	Wall Street Analysts Think Omega Therapeutics, Inc. (OMGA) Could Surge 48.23%: Read This Before Placing a Bet (Zacks)
May-04-23 08:35AM	Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Apr-27-23 07:00AM	Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting (GlobeNewswire) +9.74%
Apr-13-23 06:33AM	Private equity firms account for 53% of Omega Therapeutics, Inc.'s (NASDAQ:OMGA) ownership, while institutions account for 32% (Simply Wall St.) +6.44%
Apr-06-23 04:01AM	Omega Therapeutics, Inc. (OMGA) Surges 19.6%: Is This an Indication of Further Gains? (Zacks) +7.79%
Mar-30-23 07:00AM	Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma (GlobeNewswire)
Mar-17-23 03:35AM	Omega Therapeutics, Inc. (OMGA) Moves 15.2% Higher: Will This Strength Last? (Zacks) +25.22%
Mar-03-23 05:01AM	When Can We Expect A Profit From Omega Therapeutics, Inc. (NASDAQ:OMGA)? (Simply Wall St.)
Mar-01-23 08:35AM	Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OMGA

Omega Therapeutics Inc

Upgrade your FINVIZ experience